Cardiomyocytes derived from human pluripotent stem cells for drug screening

Pharmacology and Therapeutics

Volumn 134, Issue 2, 2012, Pages 180-188

  Zeevi Levin, Naama ^a,b   Itskovitz Eldor, Joseph ^a,b,c   Binah, Ofer ^a,b  

^a The Sohnis Family Stem Cells Center   (Israel)

^b TECHNION ISRAEL INSTITUTE OF TECHNOLOGY   (Israel)

^c Ruth and Bruce Rappaport Faculty of Medicine ^*  (Israel)

Author keywords

Cardiomyocytes; Drug screening; Human pluripotent stem cells

Indexed keywords

1 [2 (6 METHYL 2 PYRIDYL)ETHYL] 4 (4 METHYLSULFONYLAMINOBENZOYL)PIPERIDINE; CALCIUM CHANNEL; CARDIOTOXIN; CISAPRIDE; DOFETILIDE; DOXORUBICIN; ERYTHROMYCIN; FLUOXETINE; IBUTILIDE; POTASSIUM CHANNEL; PROCAINAMIDE; QUINIDINE; SODIUM CHANNEL; SOTALOL; TERFENADINE; VERAPAMIL;

ANGINA PECTORIS; BRUGADA SYNDROME; CALCIUM TRANSPORT; CARDIOTOXICITY; CATECHOLAMINERGIC POLYMORPHIC VENTRICULAR TACHYCARDIA; CELL DIFFERENTIATION; CONGESTIVE CARDIOMYOPATHY; DISEASE MODEL; DRUG FATALITY; DRUG SCREENING; ELECTROCARDIOGRAM; EXCITATION CONTRACTION COUPLING; HEART ARRHYTHMIA; HEART MUSCLE CELL; HEART MUSCLE CONDUCTION DISTURBANCE; HEART MUSCLE FIBER MEMBRANE POTENTIAL; HEART RATE; HEART RIGHT VENTRICLE DYSPLASIA; HEART VENTRICLE REMODELING; HUMAN; HYPERTENSION; HYPERTROPHIC CARDIOMYOPATHY; LONG QT SYNDROME; NONHUMAN; PLURIPOTENT STEM CELL; PRIORITY JOURNAL; QRS COMPLEX; QT INTERVAL; QT PROLONGATION; RESTRICTIVE CARDIOMYOPATHY; REVIEW; SARCOPLASMIC RETICULUM; SINUS NODE DYSFUNCTION; SYNCOPE; TORSADE DES POINTES;

ANIMALS; DRUG EVALUATION, PRECLINICAL; HUMANS; MYOCYTES, CARDIAC; PLURIPOTENT STEM CELLS;

EID: 84859156845     PISSN: 01637258     EISSN: 1879016X     Source Type: Journal    
DOI: 10.1016/j.pharmthera.2012.01.005     Document Type: Review

References (71)

1. R. Altena, P.J. Perik, D.J. van Veldhuisen, E.G. de Vries, and J.A. Gietema Cardiovascular toxicity caused by cancer treatment: strategies for early detection Lancet Oncol 10 2009 391 399
2. H. Andersson, D. Steel, J. Asp, K. Dahlenborg, M. Jonsson, and A. Jeppsson Assaying cardiac biomarkers for toxicity testing using biosensing and cardiomyocytes derived from human embryonic stem cells J Biotechnol 150 2010 175 181
3. A. Berdichevski, G. Meiry, F. Milman, I. Reiter, O. Sedan, and S. Eliyahu TVP1022 protects neonatal rat ventricular myocytes against doxorubicin-induced functional derangements J Pharmacol Exp Ther 332 2010 413 420
4. S. Bollini, N. Smart, and P.R. Riley Resident cardiac progenitor cells: at the heart of regeneration J Mol Cell Cardiol 50 2011 296 303
5. M. Bourajjaj, A.S. Armand, P.A. da Costa Martins, B. Weijts, R. van der Nagel, and S. Heeneman NFATc2 is a necessary mediator of calcineurin-dependent cardiac hypertrophy and heart failure J Biol Chem 283 2008 22295 22303
6. S.R. Braam, and C.L. Mummery Human stem cell models for predictive cardiac safety pharmacology Stem Cell Res 4 2010 155 156
7. S.R. Braam, L. Tertoolen, A. van de Stolpe, T. Meyer, R. Passier, and C.L. Mummery Prediction of drug-induced cardiotoxicity using human embryonic stem cell-derived cardiomyocytes Stem Cell Res 4 2010 107 116
8. R.S. Bresalier, R.S. Sandler, H. Quan, J.A. Bolognese, B. Oxenius, and K. Horgan Cardiovascular events associated with rofecoxib in a colorectal adenoma chemoprevention trial N Engl J Med 352 2005 1092 1102 (Pubitemid 40365350)
9. X. Carvajal-Vergara, A. Sevilla, S.L. D'Souza, Y.S. Ang, C. Schaniel, and D.F. Lee Patient-specific induced pluripotent stem-cell-derived models of LEOPARD syndrome Nature 465 2010 808 812
10. M.C. Casimiro, B.C. Knollmann, E.N. Yamoah, L. Nie, J.C. Vary Jr., and S.G. Sirenko Targeted point mutagenesis of mouse Kcnq1: phenotypic analysis of mice with point mutations that cause Romano-Ward syndrome in humans Genomics 84 2004 555 564 (Pubitemid 39037166)
11. O. Caspi, I. Itzhaki, I. Kehat, A. Gepstein, G. Arbel, and I. Huber In vitro electrophysiological drug testing using human embryonic stem cell derived cardiomyocytes Stem Cells Dev 18 2009 161 172
12. F. Charpentier, A. Bourge, and J. Merot Mouse models of SCN5A-related cardiac arrhythmias Prog Biophys Mol Biol 98 2008 230 237
13. A. Colman, and O. Dreesen Pluripotent stem cells and disease modeling Cell Stem Cell 5 2009 244 247
14. 2+ handling and the role of sarcoplasmic reticulum in the contraction Stem Cells 24 2006 236 245 (Pubitemid 44464791)
15. O. Ertracht, E. Liani, N. Bachner-Hinenzon, O. Bar-Am, L. Frolov, and E. Ovcharenko The cardioprotective efficacy of TVP1022 in a rat model of ischaemia/reperfusion Br J Pharmacol 163 2011 755 769
16. A.L. Ferreira, L.S. Matsubara, and B.B. Matsubara Anthracycline-induced cardiotoxicity Cardiovasc Hematol Agents Med Chem 6 2008 278 281
17. I. Germanguz, O. Sedan, N. Zeevi-Levin, R. Shtrichman, E. Barak, and A. Ziskind Molecular characterization and functional properties of cardiomyocytes derived from human inducible pluripotent stem cells J Cell Mol Med 15 2011 38 51
18. M. Gherghiceanu, L. Barad, A. Novak, I. Reiter, J. Itskovitz-Eldor, and O. Binah Cardiomyocytes derived from human embryonic and induced pluripotent stem cells: comparative ultrastructure J Cell Mol Med 15 2009 2539 2551
19. M.K. Gupta, D.J. Illich, A. Gaarz, M. Matzkies, F. Nguemo, and K. Pfannkuche Global transcriptional profiles of beating clusters derived from human induced pluripotent stem cells and embryonic stem cells are highly similar BMC Dev Biol 10 2010 98
20. A. Haase, R. Olmer, K. Schwanke, S. Wunderlich, S. Merkert, and C. Hess Generation of induced pluripotent stem cells from human cord blood Cell Stem Cell 5 2009 434 441
21. J.Q. He, Y. Ma, Y. Lee, J.A. Thomson, and T.J. Kamp Human embryonic stem cells develop into multiple types of cardiac myocytes: action potential characterization Circ Res 93 2003 32 39 (Pubitemid 36859038)
22. B. Hughes 2008 FDA drug approvals Nat Rev Drug Discov 8 2009 93 96
23. J.K. Ichida, J. Blanchard, K. Lam, E.Y. Son, J.E. Chung, and D. Egli A small-molecule inhibitor of tgf-Beta signaling replaces sox2 in reprogramming by inducing nanog Cell Stem Cell 5 2009 491 503
24. I. Itzhaki, L. Maizels, I. Huber, L. Zwi-Dantsis, O. Caspi, and A. Winterstern Modelling the long QT syndrome with induced pluripotent stem cells Nature 471 2011 225 229
25. I. Itzhaki, S. Rapoport, I. Huber, I. Mizrahi, L. Zwi-Dantsis, and G. Arbel Calcium handling in human induced pluripotent stem cell derived cardiomyocytes PLoS One 6 2011 e18037
26. M.K. Jonsson, G. Duker, C. Tropp, B. Andersson, P. Sartipy, and M.A. Vos Quantified proarrhythmic potential of selected human embryonic stem cell-derived cardiomyocytes Stem Cell Res 4 2010 189 200
27. M.K. Jonsson, T.A. van Veen, M.-J. Goumans, M.A. Vos, G. Duker, and P. Sartipy Improvement of cardiac efficacy and safety models in drug discovery by the use of stem cell-derived cardiomyocytes Expert Opinion on Drug Discovery 4 2009 357 372
28. P.J. Kannankeril, and D.M. Roden Drug-induced long QT and torsade de pointes: recent advances Curr Opin Cardiol 22 2007 39 43 (Pubitemid 44901054)
29. I. Kehat, D. Kenyagin-Karsenti, M. Snir, H. Segev, M. Amit, and A. Gepstein Human embryonic stem cells can differentiate into myocytes with structural and functional properties of cardiomyocytes J Clin Invest 108 2001 407 414 (Pubitemid 32730787)
30. M.J. Killeen Drug-induced arrhythmias and sudden cardiac death: implications for the pharmaceutical industry Drug Discov Today 14 2009 589 597
31. Y. Kleiner, O. Bar-Am, T. Amit, A. Berdichevski, E. Liani, and G. Maor TVP1022 and propargylamine protect neonatal rat ventricular myocytes against doxorubicin-induced and serum starvation-induced cardiotoxicity J Cardiovasc Pharmacol 52 2008 268 277
32. I. Kola, and J. Landis Can the pharmaceutical industry reduce attrition rates? Nat Rev Drug Discov 3 2004 711 715 (Pubitemid 39173511)
33. M.A. Laflamme, K.Y. Chen, A.V. Naumova, V. Muskheli, J.A. Fugate, and S.K. Dupras Cardiomyocytes derived from human embryonic stem cells in pro-survival factors enhance function of infarcted rat hearts Nat Biotechnol 25 2007 1015 1024 (Pubitemid 47517637)
34. J. Liu, J.D. Fu, C.W. Siu, and R.A. Li Functional sarcoplasmic reticulum for calcium handling of human embryonic stem cell-derived cardiomyocytes: insights for driven maturation Stem Cells 25 2007 3038 3044 (Pubitemid 350294429)
35. 2+ handling properties of human embryonic stem cell-derived cardiomyocytes by calsequestrin expression Am J Physiol Cell Physiol 297 2009 C152 159
36. V.A. Maltsev, J. Rohwedel, J. Hescheler, and A.M. Wobus Embryonic stem cells differentiate in vitro into cardiomyocytes representing sinus nodal, atrial and ventricular cell types Mech Dev 44 1993 41 50 (Pubitemid 24037697)
37. A. Martinez-Fernandez, T.J. Nelson, Y. Ikeda, and A. Terzic c-MYC independent nuclear reprogramming favors cardiogenic potential of induced pluripotent stem cells J Cardiovasc Transl Res 3 2010 13 23
38. E. Matsa, D. Rajamohan, E. Dick, L. Young, I. Mellor, and A. Staniforth Drug evaluation in cardiomyocytes derived from human induced pluripotent stem cells carrying a long QT syndrome type 2 mutation Eur Heart J 32 2011 952 962
39. T. Meyer, C. Leisgen, B. Gonser, and E. Gunther QT-screen: high-throughput cardiac safety pharmacology by extracellular electrophysiology on primary cardiac myocytes Assay Drug Dev Technol 2 2004 507 514 (Pubitemid 39619093)
40. A. Moretti, M. Bellin, A. Welling, C.B. Jung, J.T. Lam, and L. Bott-Flugel Patient-specific induced pluripotent stem-cell models for long-QT syndrome N Engl J Med 363 2010 1397 1409
41. C. Mummery, D. Ward-van Oostwaard, P. Doevendans, R. Spijker, S. van den Brink, and R. Hassink Differentiation of human embryonic stem cells to cardiomyocytes: role of coculture with visceral endoderm-like cells Circulation 107 2003 2733 2740 (Pubitemid 36667249)
42. A. Novak, R. Shtrichman, I. Germanguz, H. Segev, N. Zeevi-Levin, and B. Fishman Enhanced reprogramming and cardiac differentiation of human keratinocytes derived from plucked hair follicles, using a single excisable lentivirus Cell Reprogram 12 2010 665 678
43. D307H patients are arrhythmogenic in response to β-adrenergic stimulation J Cell Mol Med 2011 [Electronic publication ahead of print]
44. T.G. Otsuji, I. Minami, Y. Kurose, K. Yamauchi, M. Tada, and N. Nakatsuji Progressive maturation in contracting cardiomyocytes derived from human embryonic stem cells: qualitative effects on electrophysiological responses to drugs Stem Cell Res 4 2010 201 213
45. I.H. Park, R. Zhao, J.A. West, A. Yabuuchi, H. Huo, and T.A. Ince Reprogramming of human somatic cells to pluripotency with defined factors Nature 451 2008 141 146
46. S. Peng, A.E. Lacerda, G.E. Kirsch, A.M. Brown, and A. Bruening-Wright The action potential and comparative pharmacology of stem cell-derived human cardiomyocytes J Pharmacol Toxicol Methods 61 2010 277 286
47. C.W. Pouton, and J.M. Haynes Embryonic stem cells as a source of models for drug discovery Nat Rev Drug Discov 6 2007 605 616 (Pubitemid 47202486)
48. S.G. Priori, and C. Napolitano Role of genetic analyses in cardiology: part I: Mendelian diseases: cardiac channelopathies Circulation 113 2006 1130 1135
49. L.L. Rubin Stem cells and drug discovery: the beginning of a new era? Cell 132 2008 549 552 (Pubitemid 351253700)
50. L. Sartiani, E. Bettiol, F. Stillitano, A. Mugelli, E. Cerbai, and M.E. Jaconi Developmental changes in cardiomyocytes differentiated from human embryonic stem cells: a molecular and electrophysiological approach Stem Cells 25 2007 1136 1144 (Pubitemid 46684873)
51. J. Satin, I. Itzhaki, S. Rapoport, E.A. Schroder, L. Izu, and G. Arbel Calcium handling in human embryonic stem cell-derived cardiomyocytes Stem Cells 26 2008 1961 1972
52. J. Satin, I. Kehat, O. Caspi, I. Huber, G. Arbel, and I. Itzhaki Mechanism of spontaneous excitability in human embryonic stem cell derived cardiomyocytes J Physiol 559 2004 479 496 (Pubitemid 39263813)
53. G. Schram, M. Pourrier, P. Melnyk, and S. Nattel Differential distribution of cardiac ion channel expression as a basis for regional specialization in electrical function Circ Res 90 2002 939 950 (Pubitemid 34633859)
54. O. Sedan, K. Dolnikov, N. Zeevi-Levin, N. Leibovich, M. Amit, and J. Itskovitz-Eldor 1,4,5-Inositol trisphosphate-operated intracellular Ca(2+) stores and angiotensin-II/endothelin-1 signaling pathway are functional in human embryonic stem cell-derived cardiomyocytes Stem Cells 26 2008 3130 3138
55. M. Snir, I. Kehat, A. Gepstein, R. Coleman, J. Itskovitz-Eldor, and E. Livne Assessment of the ultrastructural and proliferative properties of human embryonic stem cell-derived cardiomyocytes Am J Physiol Heart Circ Physiol 285 2003 H2355 2363
56. G.S. Soor, A. Luk, E. Ahn, J.R. Abraham, A. Woo, and A. Ralph-Edwards Hypertrophic cardiomyopathy: current understanding and treatment objectives J Clin Pathol 62 2009 226 235
57. A.C. Sturzu, and S.M. Wu Developmental and regenerative biology of multipotent cardiovascular progenitor cells Circ Res 108 2011 353 364
58. K. Takahashi, K. Tanabe, M. Ohnuki, M. Narita, T. Ichisaka, and K. Tomoda Induction of pluripotent stem cells from adult human fibroblasts by defined factors Cell 131 2007 861 872 (Pubitemid 350138099)
59. K. Takahashi, and S. Yamanaka Induction of pluripotent stem cells from mouse embryonic and adult fibroblast cultures by defined factors Cell 126 2006 663 676 (Pubitemid 44233629)
60. T. Tanaka, S. Tohyama, M. Murata, F. Nomura, T. Kaneko, and H. Chen In vitro pharmacologic testing using human induced pluripotent stem cell-derived cardiomyocytes Biochem Biophys Res Commun 385 2009 497 502
61. D.A. Terrar, C.M. Wilson, S.G. Graham, S.M. Bryant, and B.M. Heath Comparison of guinea-pig ventricular myocytes and dog Purkinje fibres for in vitro assessment of drug-induced delayed repolarization J Pharmacol Toxicol Methods 56 2007 171 185 (Pubitemid 47375123)
62. J.A. Thomson, J. Itskovitz-Eldor, S.S. Shapiro, M.A. Waknitz, J.J. Swiergiel, and V.S. Marshall Embryonic stem cell lines derived from human blastocysts Science 282 1998 1145 1147 (Pubitemid 28516247)
63. A. Tomescot, J. Leschik, V. Bellamy, G. Dubois, E. Messas, and P. Bruneval Differentiation in vivo of cardiac committed human embryonic stem cells in postmyocardial infarcted rats Stem Cells 25 2007 2200 2205 (Pubitemid 47480478)
64. C. Xu, S. Police, N. Rao, and M.K. Carpenter Characterization and enrichment of cardiomyocytes derived from human embryonic stem cells Circ Res 91 2002 501 508
65. + embryonic-stem-cell-derived population Nature 453 2008 524 528 (Pubitemid 351733312)
66. N. Yokoo, S. Baba, S. Kaichi, A. Niwa, T. Mima, and H. Doi The effects of cardioactive drugs on cardiomyocytes derived from human induced pluripotent stem cells Biochem Biophys Res Commun 387 2009 482 488
67. J. Yu, M.A. Vodyanik, K. Smuga-Otto, J. Antosiewicz-Bourget, J.L. Frane, and S. Tian Induced pluripotent stem cell lines derived from human somatic cells Science 318 2007 1917 1920
68. J. Zhang, G.F. Wilson, A.G. Soerens, C.H. Koonce, J. Yu, and S.P. Palecek Functional cardiomyocytes derived from human induced pluripotent stem cells Circ Res 104 2009 e30 41
69. H. Zhou, S. Wu, J.Y. Joo, S. Zhu, D.W. Han, and T. Lin Generation of induced pluripotent stem cells using recombinant proteins Cell Stem Cell 4 2009 381 384
70. W.Z. Zhu, L.F. Santana, and M.A. Laflamme Local control of excitation-contraction coupling in human embryonic stem cell-derived cardiomyocytes PLoS One 4 2009 e5407
71. L. Zwi, O. Caspi, G. Arbel, I. Huber, A. Gepstein, and I.H. Park Cardiomyocyte differentiation of human induced pluripotent stem cells Circulation 120 2009 1513 1523